-
Mashup Score: 34Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis | Radiology - 3 month(s) ago
Background Prostate MRI for the detection of clinically significant prostate cancer (csPCa) is standardized by the Prostate Imaging Reporting and Data System (PI-RADS), currently in version 2.1. A systematic review and meta-analysis infrastructure with a 12-month update cycle was established to evaluate the diagnostic performance of PI-RADS over time. Purpose To provide estimates of diagnostic accuracy and cancer detection rates (CDRs) of PI-RADS version 2.1 categories for prostate MRI, which is required for further evidence-based patient management. Materials and Methods A systematic search of PubMed, Embase, Cochrane Library, and multiple trial registers (English-language studies published from March 1, 2019, to August 30, 2022) was performed. Studies that reported data on diagnostic accuracy or CDRs of PI-RADS version 2.1 with csPCa as the primary outcome were included. For the meta-analysis, pooled estimates for sensitivity, specificity, and CDRs were derived from extracted data at
Source: pubs.rsna.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4
Verstuur gratis grote bestanden met TransferXL ✔ zonder registratie ✔ veilig en snel bestanden uploaden ✔ bestandsoverdracht tot 200 GB ✔ via e-mail of link
Source: www.transferxl.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17
Capturing the Essence of Nature: A Study in Contrast by Jelle Barentsz | Category: Fine Art Photography – Nature | European Photography Awards
Source: europeanphotoawards.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9Ferumoxtran-10-enhanced MRI for pre-operative metastatic lymph node detection in pancreatic, duodenal, or periampullary adenocarcinoma - 5 month(s) ago
European Radiology – To assess 3-Tesla (3-T) ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRI in detecting lymph node (LN) metastases for resectable adenocarcinomas of the pancreas,…
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 30Registration is open! 12th ESUR Prostate MRI - 9 month(s) ago
Data Protection InformationResponsible: THEORIA CONGRESOS (Hernández Tena Congresos S.L; Purpose: to provide you with the services you have requested, attend your requests for information and send you commercial communications; Legitimation: Execution of contract, Legitimate interest of the responsible or Consent of the Interested Party. Transfers: Your data will not be transferred to third…
Source: 7s7y.mjt.luCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 14The association between patient and disease characteristics, and the risk of disease progression in patients with prostate cancer on active surveillance - 9 month(s) ago
World Journal of Urology – The objective of this study was to identify and assess patient and disease characteristics associated with an increased risk of disease progression in men with prostate…
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15Registration is open! 12th ESUR Prostate MRI - 10 month(s) ago
Data Protection InformationResponsible: THEORIA CONGRESOS (Hernández Tena Congresos S.L; Purpose: to provide you with the services you have requested, attend your requests for information and send you commercial communications; Legitimation: Execution of contract, Legitimate interest of the responsible or Consent of the Interested Party. Transfers: Your data will not be transferred to third…
Source: 7s7y.mjt.luCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17Quantification and significance of extraprostatic findings on prostate MRI: a retrospective analysis and three-tier classification - Insights into Imaging - 11 month(s) ago
Objectives To quantify extraprostatic findings (EPFs) on prostate MRI, estimate the proportion of reported and unreported EPFs, assess their clinical importance, and propose standardized reporting of EPFs. Materials and methods Prostate 3-T MRI studies, reports, and clinical data from 623 patients (age 67.9 ± 8.2 years) were retrospectively analyzed and re-evaluated for the presence of EPFs and their clinical significance: E1—no finding or findings that have no clinical significance; E2—potentially significant findings; and E3—significant findings. Results Secondary reading identified 1236 EPFs in 593 patients (1.98 ± 1.13 EPFs per patient, no EPFs in 30 patients), from which 468 (37.8%) were mentioned in the original report. The most common findings included diverticulosis (44% of patients), hydrocele (34%), inguinal fat hernia (16%), and bladder wall trabecular hypertrophy (15%). There were 80 (6.5%) E2 EPFs and 30 (2.4%) E3 EPFs. From E3 EPFs, 10 (33%) were not originally reported.
Source: insightsimaging.springeropen.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media? - 1 year(s) ago
European Radiology – To assess the visibility of clinically significant prostate cancer (PCA) lesions on the sequences multiparametric MRI of the prostate (mpMRI) and to evaluate whether the…
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media? - 1 year(s) ago
European Radiology – To assess the visibility of clinically significant prostate cancer (PCA) lesions on the sequences multiparametric MRI of the prostate (mpMRI) and to evaluate whether the…
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
https://t.co/UtNz5jZcEc Evaluating diagnostic performance of PI-RADS (P)v2.1 to detect csPCa 70 studies (2019-22); n=13,330 Distribution: P3=19% -> Quality suboptimal P≥ 3: 96% sens 43% spec AUC 0.86 P≥ 4: 89% sens 66% spec AUC 0.89 CDRs: P 1=6% P2=5% P3=9% P4=54% P5=84%